NCT02021669View on ClinicalTrials.gov

Omega-3 for Depression and Other Cardiac Risk Factors - 2

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 14, 2014

Primary Completion Date

September 13, 2018

Study Completion Date

September 13, 2018

Conditions
Depression
Interventions
DRUG

Omega-3 supplement

Two grams of the EPA form of omega-3 daily and 50 mgs of sertraline daily for 10 weeks

DRUG

Placebo

Two grams of corn oil plus 50 mg of sertraline daily for 10 weeks.

Trial Locations (1)

63108

Washington University Medical Center, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER

NCT02021669 - Omega-3 for Depression and Other Cardiac Risk Factors - 2 | Biotech Hunter | Biotech Hunter